Boryung Pharmaceutical Co., Ltd: Hypertension trials

The registry lists 44 Hypertension studies with Boryung Pharmaceutical Co., Ltd as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 14Phase 2 6Phase 3 13Phase 4 4No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and HypertensionRecruitingNCT05970237
• FimasaRtan-basEd BP Targets After Drug SwitcHingCompletedNCT03649646Results posted
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male SubjectsCompletedNCT02704702Phase 1Results posted
• Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)CompletedNCT02385721Results posted
• Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension PatientsCompletedNCT00922480Phase 3Results posted
• A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT00922441Phase 2Results posted
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy VolunteersCompletedNCT06008028Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy VolunteersCompletedNCT06008015Phase 1
• A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaCompletedNCT05930028Phase 3
• A Study to Evaluate the Efficacy and Safety of BR1015 Combination TherapyCompletedNCT05878561Phase 3
• A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy VolunteersCompletedNCT05372380Phase 1
• A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy VolunteersCompletedNCT05097794Phase 1
• A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and DyslipidemiaCompletedNCT04554953
• BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine CombinationCompletedNCT03991442Phase 3
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy VolunteersCompletedNCT03609294Phase 1
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03338426Phase 3
• Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE StudyCompletedNCT03254914
• A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male VolunteersCompletedNCT03250052Phase 1
• Fimasartan in the Senior SubjectsCompletedNCT03246555Phase 3
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03156842Phase 3
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male SubjectsCompletedNCT02920047Phase 1
• A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination TabletCompletedNCT02566187Phase 1
• Fimasartan Achieving SBP Target (FAST) StudyCompletedNCT02495324Phase 4
• Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male VolunteersCompletedNCT02397590Phase 1
• Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male SubjectsCompletedNCT02397538Phase 1
• Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)CompletedNCT02394392
• A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideCompletedNCT02222480Phase 2
• to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and RosuvastatinCompletedNCT02205190Phase 1
• To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual TabletsCompletedNCT02205151Phase 1
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and DyslipidemiaCompletedNCT02166814Phase 3
• Fimasartan/Amlodipine Combination Phase IIICompletedNCT02152306Phase 3
• Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSionCompletedNCT02022774
• To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and RosuvastatinCompletedNCT01921946Phase 1
• A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT01878201Phase 2
• Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive PatientsCompletedNCT01736488Phase 4
• A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential HypertensionCompletedNCT01672476Phase 3
• A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential HypertensionCompletedNCT01518998Phase 2
• A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapyCompletedNCT01258673Phase 3
• The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
• Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)CompletedNCT00937651Phase 2
• Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension PatientsCompletedNCT00923611Phase 2
• Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive PatientsCompletedNCT00386529Phase 4
• The Effects of Cilnidipine on Metabolic Syndrome ImprovementCompletedNCT00325936Phase 4
• Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With HypertensionCompletedNCT00325637Phase 3